GEMS (GE Medical Systems) lines up PET (positron emission tomography) and CT (computed tomography) for rapid cancer treatment:
This article was originally published in Clinica
Executive Summary
Faster cancer treatment "than ever before" is promised by GE Medical Systems with its GE Discovery LS, which combines a GEMS CT scanner and advanced PET system. Faster diagnosis will optimise the potential breakthrough effect of new cancer therapies, indicates Homer Macapinlac, a director and PET specialist at the University of Texas MD Anderson Cancer Center. The results of a Swiss survey showed that use of the Discovery system led to a 60% improvement in surgeons' ability to pinpoint tumours, said GEMS.
You may also be interested in...
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip